EMEA-000235-PIP02-10-M02

Key facts

Invented name
Abilify
Active substance
aripiprazole
Therapeutic area
Psychiatry
Decision number
P/0256/2012
PIP number
EMEA-000235-PIP02-10-M02
Pharmaceutical form(s)
  • Tablet
  • Orodispersible tablet
  • Oral solution
  • Solution for injection
Condition(s) / indication(s)
  • Treatment of bipolar affective disorder
  • Treatment of schizophrenia
Route(s) of administration
  • Oral use
  • Intramuscular use
Contact for public enquiries
Otsuka Pharmaceutical Europe Ltd.
E-mail: medinfo.emea@bms.com
Country: United Kingdom
Tel. +44 1895 523686
Fax +44 1895 52378
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000235-PIP02-10-M02
Compliance opinion date
24/06/2016
Compliance outcome
positive

Decision

Related content

How useful was this page?

Add your rating